ArticleNoise & health
The Impact of Noise Reduction Measures during Noise-Sensitive Periods on Vertigo Symptoms and Vestibular Function in Patients with Ménière's Disease.
Article in Noise & health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMénière's disease is a chronic vestibular disorder characterised by vertigo, hearing loss and tinnitus, with noise exposure potentially exacerbating symptoms. This study aimed to evaluate the influence of noise reduction measures during noise-sensitive periods on vertigo symptoms and vestibular function in affected patients.
methodsThis retrospective study included 223 patients diagnosed with Ménière's disease between May 2021 and June 2023. Participants were divided into two groups: the noise reduction measure group (NR group, n = 108) and the non-noise reduction measure group (NNR group, n = 115). Assessments included the Dizziness Handicap Inventory (DHI), Visual Analogue Scale (VAS) for vertigo severity, Pure Tone Audiometry (PTA), video Head Impulse Test, vestibular evoked myogenic potentials, caloric tests, Tinnitus Handicap Inventory (THI), Hospital Anxiety and Depression Scale (HADS) and the 36-Item Short Form Health Survey (SF-36). All measures were obtained at baseline and 3 months after the treatment initiation. Statistical comparisons between groups were performed using independent samples t-tests and chi-square tests, as appropriate.
resultsAt the 3-month follow-up, the NR group demonstrated significantly greater improvements than the NNR group in THI (P = 0.011), DHI (P = 0.014), VAS (P < 0.001), PTA thresholds (P = 0.007), vestibular function parameters (all P < 0.05), HADS for anxiety (P = 0.020), HADS for depression (P = 0.014) and multiple SF-36 domains (P < 0.05). The basic vertigo control rate was also higher in the NR group than in the NNR group (P = 0.003).
conclusionImplementing noise reduction measures during noise-sensitive periods significantly improved vertigo symptoms, reduced tinnitus handicap and enhanced hearing function in patients with Ménière's disease, suggesting that this approach may be a valuable adjunctive approach to standard medical treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.